Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy
PHASE2Not yet recruitingINTERVENTIONAL
Enrollment
32
Participants
Timeline
Start Date
December 1, 2023
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
Conditions
Metastatic Breast Cancer
Interventions
COMBINATION_PRODUCT
Meritup oral solution
chemotherapy + Meritup
All Listed Sponsors
collaborator
Phytofound Biotech Co., Ltd.
UNKNOWN
lead
Chung Shan Medical University
OTHER
NCT06151249 - Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy | Biotech Hunter | Biotech Hunter